Covid-19 Vaccine Will Be Administered Without Clinical Trial – NAFDAC

Coronavirus pandemic or Covid-19
Spread the love


The National Agency for food and medication organization, NAFDAC, has said the arranged turn out of Covid immunizations in Nigeria, expected to start in January won’t be exposed to new clinical preliminaries before they are controlled to residents. stunned

The representative of the office, Sayo Akintola, who made this known during a meeting with newsmen said neighborhood preliminaries for the immunization were pointless since the antibody was at that point confirmed by the World Health Organization.

“In all actuality once an immunization is affirmed by the WHO, it is accepted that it has gone through some fundamental phases of the preliminary.

READ:  Senate to State House officials: Buhari, Others Must Stop Embarking On Foreign Medical Trips

“For the WHO to endorse an antibody, it probably experienced a progression of preliminaries to a great extent,” he said.

He, in any case, clarified that an example of the immunization will be taken to the lab for its “wellbeing and adequacy” to be learned before vaccination.

Review that the Nigeria Medical Association had requested the government to do its assessment from the COVID-19 antibody prior to managing it on Nigerians.

Yet, with NAFDAC’s position, Nigeria’s wellbeing specialists might just continue with immunizations, confiding in WHO’s ability.

On the off chance that the immunization ultimately shows up in the nation, around 40 million Nigerians may get it for nothing.

READ:  Covid 19: Kogi Govt Assures Commitment To Fighting The Pandemic, Despite Reservations.

This is as prior unveiled by the Presidential Taskforce on COVID-19, following President Buhari’s mandate to continue with acquirement courses of action.


Be the first to comment

Leave a Reply

Your email address will not be published.